The most commonly reported side effects of ferrous citrate fe-59 include dyspnoea, drug interaction, and diarrhoea, based on 76 FDA adverse event reports from 2005 to 2025.
Percentages show how often each reaction appears relative to total reports for ferrous citrate fe-59.
These are voluntary reports and do not establish that ferrous citrate fe-59 caused these reactions.
Report severity
Seriousness is determined by the reporter, not by OpenClaim.
Other drugs that appear in adverse event reports alongside ferrous citrate fe-59. Drugs flagged as a suspected cause appear in the first column. Drugs taken at the same time but not suspected appear in the second.
Also suspected
Taken alongside
Co-occurrence in adverse event reports does not establish a drug interaction. Patients often take multiple medications, and these lists reflect prescribing patterns rather than causal relationships. Consult a healthcare provider about potential drug interactions.
52.6% of ferrous citrate fe-59 adverse event reports involve female patients and 43.4% involve male patients. The largest age group is elderly at 59%. These figures reflect who reports side effects, not underlying risk.
Sex
Age group
Conditions and purposes for which patients were taking ferrous citrate fe-59 when the adverse event was reported.
Ferrous Citrate Fe-59 is sold under the brand name Ferrous Citrate Fe 59.
An upward trend reflects increased FAERS reporting overall, not necessarily increased risk.
Ask OpenClaim about your specific drug combination. Get a sourced report using FDA data, drug labels, and medical literature.